These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29218249)

  • 21. Analyzing the Type II Transmembrane Serine Protease Hepsin-Dependent Basement Membrane Remodeling in 3D Cell Culture.
    Pant SM; Belitskin D; Ala-Hongisto H; Klefström J; Tervonen TA
    Methods Mol Biol; 2018; 1731():169-178. PubMed ID: 29318553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine kallikrein-4 activation, glycosylation, activity, and expression in prokaryotic and eukaryotic hosts.
    Ryu O; Hu JC; Yamakoshi Y; Villemain JL; Cao X; Zhang C; Bartlett JD; Simmer JP
    Eur J Oral Sci; 2002 Oct; 110(5):358-65. PubMed ID: 12664466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepsin activates prostasin and cleaves the extracellular domain of the epidermal growth factor receptor.
    Chen M; Chen LM; Lin CY; Chai KX
    Mol Cell Biochem; 2010 Apr; 337(1-2):259-66. PubMed ID: 19911255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
    Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
    J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
    Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
    J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the kallikrein family: intracellular localization, alternative cDNA forms, and Regulation by multiple hormones.
    Korkmaz KS; Korkmaz CG; Pretlow TG; Saatcioglu F
    DNA Cell Biol; 2001 Jul; 20(7):435-45. PubMed ID: 11506707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
    Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
    Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of kallikrein-related peptidase-4 in oral cancer.
    Papagerakis P; Pannone G; Zheng LI; Athanassiou-Papaefthymiou M; Yamakoshi Y; McGuff HS; Shkeir O; Ghirtis K; Papagerakis S
    Anticancer Res; 2015 Apr; 35(4):1861-6. PubMed ID: 25862839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepsin: a multifunctional transmembrane serine protease in pathobiology.
    Li S; Wang L; Sun S; Wu Q
    FEBS J; 2021 Sep; 288(18):5252-5264. PubMed ID: 33300264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of type II transmembrane serine protease-mediated signaling in cancer.
    Tanabe LM; List K
    FEBS J; 2017 May; 284(10):1421-1436. PubMed ID: 27870503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14.
    Borgoño CA; Michael IP; Shaw JL; Luo LY; Ghosh MC; Soosaipillai A; Grass L; Katsaros D; Diamandis EP
    J Biol Chem; 2007 Jan; 282(4):2405-22. PubMed ID: 17110383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression, structure, and function of enamel proteinases.
    Simmer JP; Hu JC
    Connect Tissue Res; 2002; 43(2-3):441-9. PubMed ID: 12489196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.
    Esumi M; Ishibashi M; Yamaguchi H; Nakajima S; Tai Y; Kikuta S; Sugitani M; Takayama T; Tahara M; Takeda M; Wakita T
    Hepatology; 2015 Feb; 61(2):437-46. PubMed ID: 25203900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteolytic activation of pro-macrophage-stimulating protein by hepsin.
    Ganesan R; Kolumam GA; Lin SJ; Xie MH; Santell L; Wu TD; Lazarus RA; Chaudhuri A; Kirchhofer D
    Mol Cancer Res; 2011 Sep; 9(9):1175-86. PubMed ID: 21875933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.
    Saunders WB; Bayless KJ; Davis GE
    J Cell Sci; 2005 May; 118(Pt 10):2325-40. PubMed ID: 15870107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.
    Samaan S; Lichner Z; Ding Q; Saleh C; Samuel J; Streutker C; Yousef GM
    Biol Chem; 2014 Sep; 395(9):991-1001. PubMed ID: 25153383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell surface-anchored serine proteases in cancer progression and metastasis.
    Martin CE; List K
    Cancer Metastasis Rev; 2019 Sep; 38(3):357-387. PubMed ID: 31529338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepsin regulates TGFβ signaling via fibronectin proteolysis.
    Belitškin D; Pant SM; Munne P; Suleymanova I; Belitškina K; Hongisto HA; Englund J; Raatikainen T; Klezovitch O; Vasioukhin V; Li S; Wu Q; Monni O; Kuure S; Laakkonen P; Pouwels J; Tervonen TA; Klefström J
    EMBO Rep; 2021 Nov; 22(11):e52532. PubMed ID: 34515392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.